STAT3 and neoplasm: Icaritin treatment (10 mg/kg) of Renca tumor-bearing mice resulted in potent inhibition of tumor growth (Fig. 5A), which correlated with a reduction in STAT3 activity in tumors (Fig. 5B) and a reduction in Bcl-xL and Cyclin E protein expression (Fig. 5B).